Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引:0
|
作者
Zorn, Kristin K. [1 ]
机构
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:738 / 740
页数:2
相关论文
共 50 条
  • [11] CARBOPLATIN AND PACLITAXEL IN OVARIAN-CANCER
    OZOLS, RF
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 78 - 83
  • [13] NEOADJUVANT TREATMENT OF OVARIAN EPITHELIAL CANCER BY CARBOPLATIN AND PACLITAXEL DOSE DENSE
    Seuwin, B.
    Linot, B.
    Abadie, S.
    Delva, R.
    Capitain, O.
    Paillocher, N.
    Oger, A. S.
    Wernert, R.
    Lorimier, G.
    Soulie, P.
    Augereau, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 555 - 557
  • [14] Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer
    Ozols, RF
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 3 - 7
  • [15] Paclitaxel/carboplatin/gemcitabine as first-line treatment of ovarian cancer
    Hansen, SW
    Geertsen, F
    Stroyer, I
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 96 - 96
  • [16] Comparison of Efficacies of Dose Dense Paclitaxel Plus Carboplatin and Conventional Paclitaxel Plus Carboplatin in the Treatment of Epithelial Ovarian Cancer
    Sunar, Veli
    Korkmaz, Vakkas
    Aslan, Koray
    Kose, Caner
    Sarici, Furkan
    Arik, Zafer
    Meydanli, Mehmet Mutlu
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 239 - 245
  • [17] Combination paclitaxel plus Carboplatin versus paclitaxel with alternating Carboplatin and cisplatin as first line treatment for advanced ovarian cancer (AOC)
    Aravantinos, G
    Fountzilas, G
    Kosmides, P
    Stathopoulos, GP
    Pavlidis, N
    Dimopoulos, MA
    Bafaloukos, D
    Papakostas, P
    Papadimitriou, C
    Nikolaides, G
    Skarlos, DV
    ANNALS OF ONCOLOGY, 1998, 9 : 66 - 66
  • [18] Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
    Zola, P.
    Ferrero, A.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 213 - 214
  • [19] Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer
    See, HT
    Thomas, DA
    Bueso-Ramos, C
    Kavanagh, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 236 - 240
  • [20] Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer
    Meerpohl, HG
    duBois, A
    Kuhnle, H
    Luck, HJ
    Kreienberg, R
    Mobus, V
    Bauknecht, T
    Kochli, O
    Bochtler, H
    Diergarten, K
    Heuser, A
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 7 - 12